M
Maren E. Shipe
Researcher at Vanderbilt University Medical Center
Publications - 14
Citations - 202
Maren E. Shipe is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Lung cancer & Internal medicine. The author has an hindex of 2, co-authored 11 publications receiving 66 citations.
Papers
More filters
Journal ArticleDOI
Developing prediction models for clinical use using logistic regression: an overview.
TL;DR: A set of guidelines and heuristics for clinicians to use to develop a logistic regression-based prediction model for binary outcomes that is intended to augment clinical decision-making is described.
Journal ArticleDOI
Modeling the Impact of Delaying the Diagnosis of Non-Small Cell Lung Cancer during COVID-19.
TL;DR: Immediate surgical biopsy of lung nodules suspicious for cancer in hospitals with low COVID-19 prevalence likely results in improved 5-year survival, however, as the risk of perioperative CO VID-19 infection increases above 13%, a delayed approach has similar or improved survival.
Journal ArticleDOI
Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules
Maren E. Shipe,Stephen A. Deppen,Shelbi Sullivan,Michael N. Kammer,Sandra L. Starnes,David O. Wilson,Pierre P. Massion,Eric L. Grogan +7 more
TL;DR: It is confirmed that histoplasma EIA testing can be useful for diagnosing benign IPN in areas with endemic histoplasmosis in a population at high risk for lung cancer.
Journal ArticleDOI
Cost-Effectiveness Analysis of Fibrinolysis vs Thoracoscopic Decortication for Early Empyema.
Maren E. Shipe,Amelia W. Maiga,Stephen A. Deppen,Diane N. Haddad,Erin A. Gillaspie,Fabien Maldonado,Benjamin D. Kozower,Eric L. Grogan +7 more
TL;DR: Surgical decortication and intrapleural fibrinolysis have nearly equivalent cost-effectiveness for early empyema in patients that can tolerate both procedures, and surgeons should consider patient-specific factors as well as the cost and effectiveness of both modalities when deciding the initial treatment.
Journal ArticleDOI
Exploring patient willingness to accept hepatitis C-infected kidneys for transplantation
Gretchen C. Edwards,Maren E. Shipe,Lindsay Smith,Christianna Gamble,David Shaffer,Beatrice P. Concepcion,Rachel C. Forbes +6 more
TL;DR: In this paper, the authors explore patient willingness to accept a kidney from HCV-infected donors compared to other high-risk donors and find that only a minority of respondents were willing to accept kidney from other high risk donors.